World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
60
Citations
26774
World Ranking
3281
National Ranking
1527

Hyam I. Levitsky publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Hyam I. Levitsky sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 132 publications — 10th percentile

10% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Hyam I. Levitsky D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Hyam I. Levitsky sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 60 D-Index — 33rd percentile

33% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Hyam I. Levitsky is affiliated with Johns Hopkins University in the United States. Their recent research contributions focus predominantly on immunology and immune cell function, with a particular interest in the reproductive system and pregnancy-related immunological processes.

Their recent papers include the following:

  • Abstract 6802: CXCR4 transgene improves in vivo migration and efficacy of engineered iPSC-derived natural killer cells, 2024, Cancer Research
  • Abstract 1320: Engineered expression of HLA-E and HLA-G protects iPSC-derived cells from killing by primary NK cells, 2024, Cancer Research
  • Abstract 3613: Screening iPSC lines for optimal characteristics of differentiation into immune effector cells for clinical programs, 2024, Cancer Research
  • POS0058 GENERATION OF iPSC-DERIVED CAR-NK, γδ CAR-T, AND αβ CAR-T CELLS WITH POTENT ACTIVITY FOR TREATMENT OF B CELL-MEDIATED AUTOIMMUNE DISEASES, 2025, Annals of the Rheumatic Diseases

Levitsky frequently collaborates with a team of researchers, including:

  • Daniel J. Perry
  • Liam Campion
  • Buddha Gurung
  • Michael Naso
  • Barry Morse

Their work is primarily published in the venue Cancer Research, with multiple publications there, as well as in Annals of the Rheumatic Diseases.

Levitsky's research spans the subfield of immunology, with their work emphasizing:

  • Immune cell function and interaction
  • Reproductive system and pregnancy

Best Publications

  • Vaccination with Irradiated Tumor Cells Engineered to Secrete Murine Granulocyte-Macrophage Colony-Stimulating Factor Stimulates Potent, Specific, and Long-Lasting Anti-Tumor Immunity

    Glenn Dranoff;Elizabeth Jaffee;Audrey Lazenby;Paul Golumbek

  • The Central Role of CD4+ T Cells in the Antitumor Immune Response

    Kenneth Hung;Robert Hayashi;Anne Lafond-Walker;Charles Lowenstein

  • Role of LAG-3 in regulatory T cells.

    Ching Tai Huang;Creg J. Workman;Dallas Flies;Xiaoyu Pan

  • Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens

    Alex Y. C. Huang;Paul Golumbek;Mojgan Ahmadzadeh;Elizabeth Jaffee

  • Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy

    Carola H. Ries;Michael A. Cannarile;Sabine Hoves;Jörg Benz

  • Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response

    Eric R. Fearon;Drew M. Pardoll;Toshiuki Itaya;Paul Golumbek

  • Treatment of Established Tumors with a Novel Vaccine That Enhances Major Histocompatibility Class II Presentation of Tumor Antigen

    Ken Yu Lin;Frank G. Guarnieri;Kevin F. Staveley-O'Carroll;Hyam I. Levitsky

  • Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4

    Paul T. Golumbek;Audrey J. Lazenby;Hyam I. Levitsky;Liz M. Jaffee

  • Induction of antigen-specific T cell anergy: An early event in the course of tumor progression

    Kevin Staveley-O’Carroll;Eduardo Sotomayor;Jami Montgomery;Ivan Borrello

  • Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer

    Jonathan W Simons;Bahar Mikhak;Ju-Fay Chang;Angelo M DeMarzo

  • Bioactivity of Autologous Irradiated Renal Cell Carcinoma Vaccines Generated by Ex Vivo Granulocyte-Macrophage Colony-Stimulating Factor Gene Transfer

    J.W. Simons;E.M. Jaffee;C.E. Weber;H.J. Levitsky

  • Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40.

    Eduardo M. Sotomayor;Ivan M Borrello;Erev Tubb;Frédérique Marie Rattis

  • High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease.

    Leo Luznik;Javier Bolaños-Meade;Marianna Zahurak;Allen R. Chen

  • ENGINEERING AN INTRACELLULAR PATHWAY FOR MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II PRESENTATION OF ANTIGENS

    Tzyy-Choou Wu;F. G. Guarnieri;K. F. Staveley-O'carroll;R. P. Viscidi

  • Depleting tumor-specific Tregs at a single site eradicates disseminated tumors

    Aurélien Marabelle;Holbrook Kohrt;Idit Sagiv-Barfi;Bahareh Ajami

  • Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines.

    Gang Zhou;Charles G. Drake;Hyam I. Levitsky

  • Activation of low avidity CTL specific for a self epitope results in tumor rejection but not autoimmunity.

    David J. Morgan;Huub T. C. Kreuwel;Shonna Fleck;Hyam I. Levitsky

  • Cross-presentation of tumor antigens by bone marrow-derived antigen-presenting cells is the dominant mechanism in the induction of T-cell tolerance during B-cell lymphoma progression.

    Eduardo M. Sotomayor;Ivan Borrello;Frédérique Marie Rattis;Alex G. Cuenca

  • In Vivo Cross-Priming of MHC Class I–Restricted Antigens Requires the TAP Transporter

    Alex Y.C Huang;Allen T Bruce;Drew M Pardoll;Hyam I Levitsky

  • Cell polarity: an examination of its behavioral expression and its consequences for polymorphonuclear leukocyte chemotaxis.

    S H Zigmond;H I Levitsky;B J Kreel

Frequent Co-Authors

Elizabeth M. Jaffee
Elizabeth M. Jaffee Johns Hopkins University
Drew M. Pardoll
Drew M. Pardoll Johns Hopkins University School of Medicine
Richard J. Jones
Richard J. Jones Johns Hopkins University
Leo Luznik
Leo Luznik Johns Hopkins University
Ephraim J. Fuchs
Ephraim J. Fuchs Johns Hopkins University
B. Douglas Smith
B. Douglas Smith Johns Hopkins University
Allan D. Hess
Allan D. Hess Johns Hopkins University
Fray F. Marshall
Fray F. Marshall Emory University
Richard C. Mulligan
Richard C. Mulligan Harvard University
William G. Nelson
William G. Nelson Johns Hopkins University School of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students pursuing Immunology in the USA, exploring related online degrees can open doors to diverse healthcare careers. Many professionals in the field transition into advanced nursing roles, where specialized knowledge is critical. For instance, understanding fnp to acnp bridge program online options can help Family Nurse Practitioners move into Acute Care Nurse Practitioner roles, expanding their scope of practice.

Accelerated pathways are also popular, allowing students to fast-track their nursing careers. Programs like accelerated nurse practitioner program provide a faster route to becoming a nurse practitioner, which can be advantageous for those seeking to combine clinical expertise with immunological insights.

For those without a nursing background, enrolling in online rn programs for non nurses offers an accessible entry point into the profession. These programs prepare students for registered nursing roles, which are critical in immunology-related healthcare settings.

Career potential is another key consideration. Salary expectations vary by state and specialty; understanding how much does a dnp make can guide decisions about further education and specialization in the immunology field. Aligning educational paths with career goals ensures both professional growth and financial reward.

Best Scientists Citing Hyam I. Levitsky

Trending Scientists

Recently Published Articles